Clinical, pathological and dermoscopic phenotype of MITF p.E318K carrier cutaneous melanoma patients.

Giulia CiccareseBruna DalmassoWilliam BrunoPaola QueiroloLorenza PastorinoVirginia AndreottiFrancesco SpagnoloEnrica TandaGiovanni PontiCesare MassoneFrancesco DragoAurora ParodiGiovanni GhigliottiMaria Antonietta PizzichettaPaola Ghiorzonull null

Published in: Journal of translational medicine (2020)

MITF+ patients tend to develop melanomas and dysplastic nevi with histopathological features, frequency and dermoscopic patterns often different from those prevalent in MITF- patients. Our results emphasize the importance of melanoma prevention programs for MITF+ patients, including dermatologic surveillance with digital follow-up.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
prognostic factors